Every 8-K that Enhanced Group Inc. (ENHA) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ENHA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ENHA filings page.
Enhanced Group Inc. (ENHA) reported audited consolidated financials of its accounting predecessor, Enhanced Ltd, which now represents the company’s historical results due to a SPAC business combination with A Paradise Acquisition Corp. accounted for as a reverse recapitalization. All prior-period share and per‑share data have been retroactively adjusted using an exchange ratio of 7.6021255 Class A shares for each legacy Enhanced share, and previously mezzanine-classified convertible preferred stock has been restated as common stock.
Enhanced Ltd is a growth‑stage sports entertainment and performance technology company developing the Enhanced Games concept. For 2025 it recorded a net loss of $26.7 million versus $4.7 million in 2024, driving an accumulated deficit of $32.0 million and a stockholders’ deficit of $1.0 million as of December 31, 2025. Cash and cash equivalents were $25.3 million, funded largely by $20.0 million of common stock and warrant issuance and $29.7 million of Simple Agreements for Future Equity. The independent auditor issued an unqualified opinion but highlighted substantial doubt about the company’s ability to continue as a going concern due to recurring losses, negative operating cash flows, and the need for additional capital.
Enhanced Group Inc. reported its first quarter as a public company for the three months ended June 30, 2026, posting revenue of $17.7 million, primarily from sponsorships tied to the inaugural Enhanced Games. It secured approximately $32 million of sponsorship contract value, much of which will be recognized over future periods as performance obligations are met.
The company recorded a net loss of $61.9 million and an Adjusted EBITDA loss of $42.7 million, reflecting heavy spending on the inaugural Games, transaction costs from the de‑SPAC merger, and higher public-company and platform-launch expenses. For the six months ended June 30, 2026, cash used in operating activities was $44.0 million, leaving cash and cash equivalents of $19.6 million at quarter-end.
To support liquidity, Enhanced completed a $50 million PIPE financing, with an additional $3.3 million from tranche two received and $13.3 million from tranche three expected around August 14, 2026. Management highlights significant brand and audience traction from the Enhanced Games and related media, and continues to develop its Live Enhanced performance medicine platform while exploring strategic M&A and partnerships.
Enhanced Group Inc. entered into a $50 million private PIPE financing, selling 12,853,468 Class A shares and 12,853,468 accompanying warrants at $3.89 per share and per warrant. The deal is led by controlling shareholder Apeiron Investment Group and includes CEO Maximilian Martin.
The financing will close in three tranches, with about $25 million expected around June 17, 2026 and the rest within roughly 45 days, subject to customary conditions. A portion of the first tranche will fully repay a working capital promissory note owed to Apeiron, with no prepayment penalty, and the remainder will support working capital and growth of Enhanced’s telehealth and consumer health platform.
The warrants carry a $3.89 exercise price, a five-year term (subject to an accelerated expiry if the stock trades at or above $20.00 for 20 consecutive days), anti-dilution adjustments for lower-priced equity financings in the first 24 months, and beneficial ownership caps generally at 4.99% or, at the holder’s election, up to 19.99%. Enhanced has agreed to register the resale of the shares and warrant shares after closing and to seek stockholder approval, via written consent from its controlling stockholder, for issuances that could exceed 19.99% of outstanding common stock or voting power.